21647 ⎘
Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups -
ANIMAL FEEDS AND VETERINARY COMPOSITIONS
#12602NUTRACEUTICAL SWEETENER COMPOSITION
#12603Herbal composition for treating CD33+ acute and chronic myeloid leukemia and a method thereof
#12604Cranberry seed oil extract and compositions containing components thereof
#12605Regulation of GSK-3alpha activity for the treatment or prevention of Alzheimer's disease
#12606COMPOSITIONS FOR ACCELERATING THE HEALING RESPONSE
#12607COMPOSITIONS AND METHODS FOR PREVENTING OR TREATING CARDIOVASCULAR DISEASES IN FELINES WITH HYPERTHYROIDISM
#12608Treatment of cancer with bio and chemotherapy
#12609METHODS AND COMPOSITIONS FOR THE TREATMENT OF CANCER
#12610COMPOSITIONS AND TREATMENTS COMPRISING 5-LIPOXYGENASE-ACTIVATING PROTEIN INHIBITORS AND NITRIC OXIDE MODULATORS
#12611Use of L-carnitine for the preparation of a medicament in the form of eye-drops for treating corneal diseases
#12612MIXTURES OR ORGANIC COMPOUNDS FOR THE TREATMENT OF AIRWAY DISEASES
#12613Stable fixed dose topical formulation
#12614Methods and compositions for tissue regeneration
#12615PHARMACEUTICAL FORMULATION, ITS USE, AND METHOD FOR ITS MANUFACTURE
#12616TREATMENT AND PREVENTION OF CARDIOVASCULAR EVENTS
#12617COMPOSITIONS FOR TREATING VASCULAR DISEASES CHARACTERIZED BY NITRIC OXIDE INSUFFICIENCY
#12618Methods, Compositions and Device for Directed and Controlled Heating and Release of Agents
#12619Methods using 3-(4-amino-1-oxo-1,3-dihydro-isoindol-2-yl)-piperidine-2,6-dione for treatment of mantle cell lymphomas
#12620METHOD OF TREATING HEMOLYTIC DISEASE
#12621Method for Production of T Cell Population
#12622Combination therapy for treating HCV infection
#12623Methods of organ regeneration using Hox11-expressing pluripotent cells
#12624COMBINATION WITH BIS (THIOHYDRAZIDE AMIDES) FOR TREATING CANCER
#12625Recombinant human albumin-interleukin-11 fusion protein with long-lasting biological effects
#12626Use of nutritional compositions for preventing disorders
#12627Method and topical formulation for treating localized edema
#12628Pharmaceutical Combination
#12629Deuterated benzylbenzene derivatives and methods of use
#12630POLYMORPH III OF 4-[4-(AMINO)-3-FLUOROPHENOXY]-N-METHYLPYRIDINE-2-CARBOXAMIDE
#12631METHODS FOR TREATMENT OF COLORECTAL CANCER USING 3-(4-AMINO-1-OXO-1,3-DIHYDRO-ISOINDOL-2-YL)-PIPERIDINE-2,6-DIONE
#12632METHODS FOR THE ADMINISTRATION OF ILOPERIDONE
#12633THERAPEUTIC COMPOSITIONS AND RELATED METHODS OF USE
#12634COMBINATION FOR USE IN THE TREATMENT OF INFLAMMATORY DISORDERS
#12635Therapeutic agent for glaucoma comprising Rho Kinhase inhibitor and prostaglandin
#12636AMINOPYRIMIDINE INHIBITORS OF HISTAMINE RECEPTORS FOR THE TREATMENT OF DISEASE
#12637Low Dose Estrogen Interrupted Hormone Replacement Therapy
#12638Ophthalmic Suspension for Ocular Use
#12639Pharmaceutical Combinations
#12640Skin-care preparations containing mupirocin and betamethasone dipropionate
#12641Drug comprising at least one gestagen
#12642Compositions and methods for the treatment of inflammatory diseases
#12643Pharmaceutical Combination Comprising 6-Dimethylaminomethyl-1-(3-methoxy-phenyl)-cyclohexane-1.3-diol and an NSAID
#12644Methods for Treating Cystic Fibrosis or Pneumonia with Bacterial Infection via Pulmonary Administration of Fosfomycin
#126451,4-benzothiepin-1,1-dioxide derivatives which are substituted with fluorine, method for producing the same, drugs containing said compounds and use thereof
#12646USE OF FIBRINOGEN AS A PROPHYLACTIC TREATMENT TO PREVENT BLEEDING DURING AND AFTER SURGERY AND AS A BIOMARKER TO IDENTIFY PATIENT WITH AN INCREASED RISK FOR EXCESSIVE BLEEDING AND BLOOD TRANSFUSION
#12647TREATMENT OF ECTOPARASITIC INFESTATION
#12648Combination therapy for the treatment of bacterial infections
#12649HYDROGEN-DISSOLVED AQUEOUS SOLUTION AND METHOD FOR PROLONGING THE LIFE DURATION OF HYDROGEN DISSOLVED IN THE AQUEOUS SOLUTION
#12650Pharmaceutical composition comprising metadoxine and garlic oil for preventing and treating alcohol-induced fatty liver and steatohepatitis
#12651COMPOSITIONS COMPRISING KAKADU PLUM EXTRACT OR ACAI BERRY EXTRACT
#12652Nutraceutical Treatments for Diabetic and Non-Diabetic Wound Healing
#12653Use of tellurium containing compounds as nerve protecting agents
#12654PHARMACEUTICAL COMPOSITION FOR TREATING CANCER AND THE SIGNALING PATHWAY THEREOF
#12655Allergen inactivating agent
#12656Method for delivering a pharmaceutical composition to patient in need thereof
#12657Pharmaceutical composition comprising tramadol and ketoprofen in association
#12658S-Nitrosothiols Containing Composition for the Treatment of Fatty Liver Diseases, Obesity and Other Diseases Associated with the Metabolic Syndrome and the Use of Such Compositions
#12659Cholestanol derivative for combined use
#12660ANTIHUMAN TNF-ALPHA ANTIBODY ACTIVITY LOWERING INHIBITOR
#12661COMPOSITIONS AND METHODS FOR MODULATION OF SUPPRESSOR T CELL ACTIVATION
#12662Uses for 4,17β-dihydroxyandrost-4-ene-3-one
#12663CBLB for treating endotoxin-mediated disorders
#12664Reducing cholesterol levels with combined use of quercetin and statin
#12665Modulation of Regulatory T Cells by Human IL-18
#12666Methods of administering a material into a patient for dermal enhancement
#12667Bone metabolism improving agent
#12668SPECIFIC BINDING PROTEINS AND USES THEREOF
#12669ANTIBODIES AGAINST ERBB3 AND USES THEREOF
#12670CHEMICALLY INDUCED INTRACELLULAR HYPERTHERMIA
#12671Non-toxic anti-cancer drug combining ascorbate, magnesium and a naphthoquinone
#12672Combination therapy using budesonide and antisense oligonucleotide targeted to IL4-receptor alpha
#12673Association of an anti-atherothrombotic agent and an anti-platelet-aggregation agent
#12674USE FOR TREATING OBESITY AND DIABETES
#12675PROPELLANT-FREE AEROSOL FORMULATION FOR INHALATION
#12676COMBINATION FOR USE IN THE TREATMENT OF INFLAMMATORY DISORDERS
#12677STABLE PHARMACEUTICAL COMPOSITION FOR OPTIMIZED DELIVERY OF AN HIV ATTACHMENT INHIBITOR
#12678METHOD OF TREATING ATRIAL FIBRILLATION
#12679Substituted triazolo-pyridazine derivatives
#12680(Aza)indole derivative and use thereof for medical purposes
#12681COMBINATIONS COMPRISING ANTIMUSCARINIC AGENTS AND CORTICOSTEROIDS
#12682NANOSOAP CONTAINING SILVER NANOPARTICLES
#12683Combination of IAP inhibitors and FLT3 inhibitors
#12684Compositions
#12685COMBINATION OF ORGANIC COMPOUNDS
#12686Method for screening modulators of apoptosis
#12687Treatment and Method for Eliminating or Reducing Foot Odor
#12688USE OF IRON CHELATOR FOR THE TREATMENT OF MYOCARDIAL INFARCTION
#12689Absorption enhancers such as E.G. BHT, BHA or propyl gallate
#12690PRODUCT AND PROCESS FOR ELEVATING LIPID BLOOD LEVELS IN LIVESTOCK
#12691NOVEL COMPOSITIONS
#12692Pharmaceutical composition for inhibiting the syndrome of snoring and preparation thereof
#12693Composition comprising the extract of crude drug complex having neuroprotective activity for preventing and treating stroke and neurodegenerative diseases
#12694Use of ribose in first response to acute myocardial infarction
#12695Anti-parasitic methods and compositions utilizing diindolylmethane-related indoles
#12696COMPOSITION AND METHOD FOR TREATING HEMORRHOIDS AND/OR ANORECTAL DISORDERS
#12697TRIMEPRAZINE AND ETHOPROPAZINE DERIVATIVES FOR PROMOTING BONE GROWTH
#12698Use of guanidinoacetic acid (salts) combination with betaine and/or choline to produced an agent that is beneficial to health
#12699STEM CELL DELIVERY OF ANTI-NEOPLASTIC MEDICINE
#12700ANTIHISTAMINE AND ANTIHISTAMINE-LIKE NASAL APPLICATION, PRODUCTS, AND METHOD
#12701METHODS AND TOPICAL FORMULATIONS COMPRISING COLLOIDAL METAL FOR TREATING OR PREVENTING SKIN CONDITIONS
#12702Compositions of PD-1 antagonists and methods of use
#12703Pharmaceutical combinations of 1-cyclopropyl-3-[3-(5-morpholin-4-ylmethyl-1H-benzoimidazol-2-yl)-1H-pyrazol-4-yl]-urea
#12704METHODS FOR INCREASING AND MOBILIZING HEMATOPOIETIC STEM CELLS
#12705TREATMENT OF PERVASIVE DEVELOPMENTAL DISORDERS
#127062-oxo-1,2-dihydro-quinoline modulators of immune function
#12707ASSOCIATION OF COMPOUNDS INHIBITING MELANOGENESIS AND USE THEREOF IN COSMETICS AND DERMATOLOGY
#12708AGENT FOR IMPROVING PERMEATION OF A DRUG INTO A NAIL AND AN EXTERNAL TREATING AGENT CONTAINING THE SAME
#12709Composition and method for treating colds
#12710Attenuation of vasoactive oxygen carrier-induced vasoconstriction
#12711Bone cement compositions having fiber-reinforcement and/or increased flowability
#12712Use of cyclopamine in the treatment of basal cell carcinoma and other tumors
#12713PHARMACEUTICAL AND NUTRACEUTICAL PRODUCTS COMPRISING VITAMIN K2
#12714Method useful for the prevention of type 2 diabetes and its complications in pre-diabetic patients with insulin resistance
#12715Dietary and pharmaceutical compositions containing carnosol and/or rosmanol and their uses
#12716Modified vaccinia virus ankara for the vaccination of neonates
#12717Aqueous compositions containing metronidazole
#12718COMBINATIONS COMPRISING BICYCLIC S1P LYASE INHIBITORS
#12719METHODS FOR TREATING CNS DISORDERS
#12720Synergistic pharmaceutical combination for the prevention or treatment of diabetes
#12721MEDICAMENT FOR TREATING CHRONIC OBSTRUCTIVE PULMONARY DISEASE
#12722COMBINATIONS COMPRISING ANTIMUSCARINIC AGENTS AND PDE4 INHIBITORS
#12723COMBINATIONS COMPRISING ANTIMUSCARINIC AGENTS AND PDE4 INHIBITORS
#12724SYNERGISTIC EFFECTS OF COMBINATIONS OF NORNICOTINE AND OPIOIDS FOR THE TREATMENT OF PAIN
#12725Methods and compositions for treating primary and secondary tumors of the central nervous system (CNS)
#12726Therapeutical Uses of Eslicarbazepine
#12727HETEROCYCLIC COMPOUNDS AS INHIBITORS OF BETA-LACTAMASES
#12728COMBINATION OF A GLUCO-KORTICOID AND BETA-CYCLODEXTRIN CONJUGATED VITAMIN A-DERIVATE COMPLEX
#12729Rifaximin anti-rectal dysfunction preparation
#12730Pharmaceutical composition combining tenatoprazole and an anti-inflammatory agent
#12731Mixture and method for reducing cholesterol using hydrophobic microparticles
#12732COMPOSITION FOR TREATMENT OF PANCREATIC CANCER
#12733Anti-viral nucleoside analogs and methods for treating viral infections, especially HIV infections
#12734Methods for treating diabetic wounds
#12735Method of treating dyspnea associated with acute heart failure
#12736Methods of use of Trk receptor modulators
#12737Antidiabetic oral insulin-biguanide combination
#12738Anti-tumor drug, medicament, composition, and use thereof
#12739Nutrient System for Individualized Responsive Dosing Regimens
#12740NUTRITIONAL SUPPLEMENT FOR PATIENTS WITH CHRONIC KIDNEY DISEASE
#12741COMPOSITIONS FOR TOPICAL APPLICATION COMPRISING A PEROXIDE AND RETINOID
#12742COMPOSITIONS AND METHODS FOR TREATING EXCESSIVE BLEEDING
#12743Performance enhancing composition and use thereof
#12744COMBINED PREPARATION FOR THE TREATMENT OF CARDIOVASCULAR DISEASES BASED ON CHRONOTHERAPY THEORY
#12745Compositions for the treatment of chronic degenerative inflammatory conditions
#12746TREATMENT FOR DARK ADAPTATION
#12747Combination antihypertensive wafer
#12748FOLINIC ACID DERIVATIVES FOR PROMOTING BONE GROWTH
#12749Hybrid cells for treating cancer patients
#12750TREATING SKIN CANCER
#12751Immuno-Stimulant Combination for Prophylaxis and Treatment of Hepatitis C
#12752NOVEL ANTICANCER CATHEPSIN FORMULATIONS AND ANTICANCER AGENT FOR USE IN COMBINED ANTICANCER THERAPY
#12753Pharmanutrient Composition(s) and System(s) for Individualized, Responsive Dosing Regimens
#12754STEM CELL TARGETING METHODS
#12755Therapeutic Composition To Improve The Effect Of The Therapy With Anti-Epidermal Growth Factor Receptor Antibodies
#12756Vaccine immunotherapy
#12757MIXTURE OF A VANILLOID RECEPTOR AGONIST AND A SUBSTANCE INHIBITING NERVE REGENERATION, USE THEREOF FOR PRODUCING A PAINKILLER, AND METHOD FOR APPLYING SAID PAINKILLER
#12758METHODS AND COMPOSITIONS FOR TREATING NEUROPATHIES
#12759COMBINATION THERAPY IN THE TREATMENT OF CANCER
#12760Devices and methods for minimizing and treating high-altitude sickness
#12761Method to Reduce Oxidative Damage and Improve Mitochondrial Efficiency
#12762Stable pharmaceutical composition
#12763PHARMACEUTICAL COMPOSITIONS COMPRISING COMBINATIONS OF AN AMPA/KAINATE ANTAGONISTIC COMPOUND AND AN INHIBITOR OF A MULTIDRUG RESISTANCE PROTEIN
#12764Co-Administration of Dopamine-Receptor Binding Compounds
#12765Combined Effects of Topiramate and Ondansetron on Alcohol Consumption
#12766ORAL DIETING COMPOSITION COMPRISING CONJUGATED LINOLEIC ACID AND CAFFEINE
#12767COMPOSITIONS AND METHODS FOR TREATING INFLAMMATORY DISORDERS
#12768Inhibitors of Bruton's tyrosine kinase
#12769Methods for treating glaucoma
#12770Compositions and methods for treating thrombocytopenia
#12771METHODS FOR IMPROVING FRONTAL BRAIN BIOENERGETIC METABOLISM
#12772Lasonolide compounds as reagents for inducing premature chromosome condensation and methods for treating disorders
#12773NOVEL ANTIBIOTIC COMPOSITIONS
#12774Methods of Use of Eggshell Polypeptides
#12775Use of VEGF-C or VEGF-D in Reconstructive Surgery
#12776Methods for treating immune disorders associated with graft transplantation with soluble CTLA4 mutant molecules
#12777COMBINATION THERAPY FOR INHIBITION OF PLATELET AGGREGATION
#12778HEMOGLOBIN ALPHA CHAIN PEPTIDE FRAGMENTS USEFUL FOR INHIBITING STEM CELL PROLIFERATION
#12779THROAT SPRAY
#12780Stimulation of the synthesis and of the activity of an isoform of lysyl oxidase-like LOXL for stimulating the formation of elastic fibers.
#12781INGESTIBLE COMPOSITIONS CONTAINING EXTRACTS
#12782COMPOUND FOR EXFOLIATING SKIN
#12783Kit for promoting hair growth
#12784Gastric retentive pharmaceutical compositions for treatment and prevention of CNS disorders
#12785BIOMATERIAL
#12786Compositions for Reducing Nicotine Withdrawal Symptoms and/or Tobacco Usage
#12787Non-Invasive Ocular Delivery of Rapamycin
#12788Biomimetic Hydroxyapatite Composite Materials and Methods for the Preparation Thereof
#12789COMPOSITION
#12790Highly potent synergistic combinations of human immunodeficiency virus (HIV) fusion inhibitors
#12791METHODS AND COMPOSITIONS FOR TREATING BONE LOSS
#12792ANTI-CANCER ANTIBODIES AGAINST LEWISy AND LEWISb ANTIGENS
#12793COMPOSITIONS AND METHODS FOR THE TREATMENT OF INFECTIONS AND TUMORS
#12794Combination Therapy with Inhibitors of HMGB and Caspase for the Treatment of Inflammatory Diseases
#12795Methods for promoting protection and regeneration of bone marrow using CXCL9 and anti-CXCL9 antibodies
#12796KIT OF PARTS COMPRISING AN ACID LABILE AND AN ACID RESISTANT PHARMACEUTICALLY ACTIVE INGREDIENT
#12797USE OF MATRIX METALLOPROTEINASE-10 (MMP-10) FOR THROMBOLYTIC TREATMENTS
#12798LIPASE-CONTAINING COMPOSITION AND METHODS OF USE THEREOF
#12799EPO DERIVATIVE-CONTAINING THERAPEUTIC AGENTS FOR BLOOD-RELATED DISEASES
#12800Steroidal compounds as melanogenesis modifiers and uses thereof
#12801RNA INTERFERENCE COMPOSITIONS AND METHODS
#12802COMBINATION S-NITROSOTHIOL PHARMACEUTICAL PRODUCTS FOR RESTORING NORMAL BREATHING RHYTHMS
#12803Methods and Compositions for Treating Inflammation and Inflammation-Related Pathologies
#12804Compositions and methods of sensitizing methicillin resistant to beta-lactam antibiotics
#12805COMBINATION OF CANNABINOIDS FOR THE TREATMENT OF PERIPHERAL NEUROPATHIC PAIN
#12806DISRUPTION OF PROGRAMMED DEATH 1 (PD-1) LIGAND TO ADJUVANT ADENO-ASSOCIATED VIRUS VECTOR VACCINES
#128071,4-benzothiepine 1,1-dioxide derivatives substituted by benzyl radicals, method for their preparation, pharmaceuticals comprising these compounds, and the use thereof
#12808Penetrating carrier, anti-fungal composition using the same and method for treatment of dermatophytes
#12809Urea and sulfamide derivatives as inhibitors of TAFIa
#12810MEDICAMENT FOR PROPHYLACTIC AND/OR THERAPEUTIC TREATMENT OF ALZHEIMER-TYPE DEMENTIA
#12811Pyrrolo[2,3-D]pyrimidine compounds
#12812Combination of N-(3-methoxy-5-methylpyrazin-2-yl)-2-(4-[1,3,4-oxadiazol-2-yl]phenyl)pyridine-3-sulphonamide and an anti-mitotic cytotoxic agent
#12813PARENTERAL FORMULATIONS OF DOPAMINE AGONISTS
#12814COMPOSITIONS FOR MANIPULATING THE LIFESPAN AND STRESS RESPONSE OF CELLS AND ORGANISMS
#12815NOVEL AZA-CYCLIC INDOLE-2-CARBOXAMIDES AND METHODS OF USE THEREOF
#12816INHIBITORS OF PROTEIN TYROSINE PHOSPHATASE FOR THE PROMOTION OF PHYSIOLOGICAL CARDIAC HYPERTROPHY
#12817Novel Compositions and Methods for Binding and Inhibiting 5-HT4 Receptor
#12818Method for treating or preventing a cardiovascular disease or condition utilizing estrogen receptor modulators based on APOE allelic profile of a mammalian subject
#12819METHOD FOR PREVENTING OR TREATING CISPLATIN-INDUCED NEPHROTOXICITY
#12820THERAPY FOR DISORDERS OF THE PROXIMAL DIGESTIVE TRACT
#12821Synergistic Pharmaceutical Composition
#12822Medicament comprising a peptide extract of avocado, which is intended for the treatment and prevention of illnesses that are linked to an immune system deficiency or oxidative stress or skin ageing or dry skin
#12823Methods for promoting organ development
#12824Modulators
#12825Composition comprising rutin and polyunsaturated fatty acid having an inhibitory activity on 5 α-reductase
#12826ANIMAL FEED COMPOSITIONS
#12827COMBINATIONS OF FORMOTEROL AND FLUTICASONE PROPIONATE FOR ASTHMA
#12828COMBINATION OF VITAMIN K AND VITAMIN K ANTAGONIST SUCH AS R-ISOMER OF WARFARIN, PHENPROCOUMON OR R-ISOMER OF PHENPROCOUMON AS ANTICOAGULANT THERAPY
#12829TRANSDERMAL RICINOLEIC ACID COMPOSITIONS
#12830METHODS FOR TREATING VIRAL DISORDERS
#12831TARGETED BIOCIDES
#12832Use of L-carnitine or an alkanoyl L-carnitine, for the preparation of a dietary supplement or medicament for the treatment of corneal disease
#12833ENDOTHELIAL PROGENITOR CELL COMPOSITIONS AND NEOVASCULARIZATION
#12834COMPOSITION AND METHOD FOR TREATMENT OF INSECT BITES
#12835METHODS FOR PREPARATION OF ANTI-ACNE FORMULATION AND COMPOSITIONS PREPARED THEREBY
#12836TOPICAL COMPOSITION
#12837Composition and method for treatment of MRSA
#12838TREATMENT OF ADDICTIVE DISORDERS
#12839Methods of treating fragile X syndrome and autism
#12840Topical formulation including diclofenac, or a pharmaceutically acceptable salt thereof
#12841Compositions and methods for promoting fat loss
#12842TOPICAL AQUEOUS COMPOSITION COMPRISING TRETINOIN
#12843Administration of adapalene and benzoyl peroxide for the long-term treatment of acne vulgaris
#12844Obesity and metabolic syndrome treatment with tanshinone derivatives which increase metabolic activity
#12845COMPOSITION USEFUL FOR THE TREATMENT OF TYPE 2 DIABETES
#12846USE OF XANTHOHUMOL AND/OR ISOXANTHOHUMOL AS AN AGENT FOR PREVENTING AND/OR COMBATING LIVER DISEASES
#12847P-Glycoprotein inhibitor comprising octilonium bromide as an effective ingredient
#12848Methods for Alzheimer's disease treatment and cognitive enhancement
#12849Combinations of Beta-2-Adrenoceptor Agonistic Benzothiazolone
#12850METHODS AND COMPOSITIONS FOR REDUCTION OF SIDE EFFECTS OF THERAPEUTIC TREATMENTS
#128511,8-naphthyridine compounds for the treatment of cancer
#12852Methods of Using Phosphoantigen for the Treatment of Cancer
#12853Methods and Compositions for Treating Migraine Pain
#12854Compositions and methods for reducing activation of alpha-1 receptors
#12855Vasoconstriction compositions and methods of use
#12856Anesthetic compositions and methods of use
#12857Compositions and methods for reversing rebound hyperemia
#12858Preferential vasoconstriction compositions and methods of use
#12859Combination Therapy For Treating Hepatitis C Infections
#12860Reverse-turn mimetics and method relating thereto
#12861ANTIBACTERIAL COMBINATION AND ITS USE
#12862Administration of fluocinolone acetonide, tretinoin and hydroquinone cream in melasma maintenance therapy
#12863RecA inhibitors with antibiotic activity, compositions and methods of use
#12864Method of treating or preventing osteoporosis comprising administering to a patient in need thereof an effective amount of pharmacuetical composition comprising benzamidine derivative or it's salt, and bisphosphonate
#12865Method of treating or preventing osteoporosis comprising administering to a patient in need thereof an effective amount of pharmaceutical composition comprising benzamidine derivatives or their salts, and alendronic acid or its salt
#12866Combinations of a pyrimidine containing NNRTI with RT inhibitors
#12867Diazoxide for the treatment of Friedreich's ataxia
#12868Cosmetic compositions
#12869Peptide and treatment for HIV-1 infection
#12870Method of correcting imbalance between bone resorption and bone formation and kits and compositions therefor
#12871Solubilized protein composition obtained from eggshell membrane
#12872Method for achieving desired glial growth factor 2 plasma levels
#12873ALPHA-LACTALBUMIN COMPOSITION
#12874Treatment Of Inflammatory Lung Conditions With Aerosolized Macrolide Antibiotics
#12875Methods for treating nucleoside-induced pain
#12876IDENTIFICATION AND CHARACTERIZATION OF HCV REPLICON VARIANTS WITH REDUCED SUSCEPTIBILITY TO BENZOFURANS, AND METHODS RELATED THERETO
#12877Body fat-reducing agent
#12878USE OF SAFFRON AND/OR SAFRANAL AND/OR CROCIN AND/OR PICROCROCIN AND/OR DERIVATIVES THEREOF AS A SATEITY AGENT FOR TREATMENT OF OBESITY
#12879IMPROVEMENTS IN RELATION TO CANCER THERAPY
#12880Mild composition for skin disinfection
#12881Broad-spectrum antiviral composition with excellent preservation stabilty
#12882Methods of therapeutic treatment of eyes
#12883PHARMACEUTICAL COMPOSITION OF ATOVAQUONE
#12884COMBINATION OF TYROSINE KINASE INHIBITOR AND HER-2/NEU FOR CANCER THERAPY
#12885SKIN TREATMENT STRIP
#12886Methods for manufacturing a composition for treating bone and/or cartilage defects
#12887Chemically defined vaccine stabiliser
#12888Antibodies against vascular endothelial growth factor receptor-1
#12889Synergistic effects
#12890CONDITIONED CELL IMMUNIZATION
#12891COMPOSITIONS INCLUDING TRICIRIBINE AND TRASTUZUMAB AND METHODS OF USE THEREOF
#12892Combinations of therapeutic agents for treating cancer
#12893COMPOSITIONS AND METHODS TO POTENTIATE COLISTIN ACTIVITY
#12894Skin repair compositions comprising circadian gene activators and a synergistic combination of 1 gene activators
#12895MODERATING THE EFFECT OF ENDOTOXINS
#12896Methods and composition of treating a flaviviridae family viral infection
#12897INTERFERON TYPE I SUPPORTING COMPOUNDS
#12898COADMINISTRATION OF ALPHA-FETOPROTEIN AND AN IMMUNOMODULATORY AGENT TO TREAT MULTIPLE SCLEROSIS
#12899ORAL DISINFECTANT, AND FOOD ADDITIVE COMPRISING THE DISINFECTANT
#12900Compositions and methods for reducing capillary permeability